A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/16 (2006.01) A61K 31/381 (2006.01) A61K 47/30 (2006.01) A61P 25/16 (2006.01)
Patent
CA 2581143
Long acting sustained-release formulation for treating Parkinson's Disease, which comprises effective amount of the dopamine receptor agonist and the biodegradable pharmaceutical polymer excipient. The weight amount of the dopamine receptor agonist in the formulation is 5-50 %, and the weight amount of the pharmaceutical polymer excipient in that is 50-95 %.
La présente invention concerne une formulation à libération lente et prolongée pour le traitement de la maladie de Parkinson, qui comprend une quantité efficace de l~agoniste du récepteur de la dopamine et l~excipient polymère pharmaceutique biodégradable. La quantité en poids de l~agoniste du récepteur de la dopamine dans la formulation est de 5 à 50 % et la quantité en poids de l~excipient polymère pharmaceutique biodégradable dans la formulation est de 50 à 95 %.
Oyen Wiggs Green & Mutala Llp
Shandong Luye Pharmaceutical Co. Ltd.
LandOfFree
Long acting sustained-release formulation containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long acting sustained-release formulation containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting sustained-release formulation containing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1741298